AbstractGet full access to this articleView all access options for this article.Get accessReferences1. Newman MJ . Invention and characterization of a systemically administered, attenuated and killed bacteria-based multiple immune receptor agonist for anti-tumor immunotherapy. Front Immunol. , 2024 Nov 7; 15:1462221. doi: 10.3389/fimmu.2024.1462221